These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 24345269)
1. The novel object recognition test in rodents in relation to cognitive impairment in schizophrenia. Rajagopal L; Massey BW; Huang M; Oyamada Y; Meltzer HY Curr Pharm Des; 2014; 20(31):5104-14. PubMed ID: 24345269 [TBL] [Abstract][Full Text] [Related]
2. Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia. Meltzer HY; Rajagopal L; Huang M; Oyamada Y; Kwon S; Horiguchi M Int J Neuropsychopharmacol; 2013 Nov; 16(10):2181-94. PubMed ID: 24099265 [TBL] [Abstract][Full Text] [Related]
3. Combined serotonin (5-HT)1A agonism, 5-HT(2A) and dopamine D₂ receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats. Oyamada Y; Horiguchi M; Rajagopal L; Miyauchi M; Meltzer HY Behav Brain Res; 2015 May; 285():165-75. PubMed ID: 25448429 [TBL] [Abstract][Full Text] [Related]
5. The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment. Meltzer HY; Horiguchi M; Massey BW Psychopharmacology (Berl); 2011 Feb; 213(2-3):289-305. PubMed ID: 21212939 [TBL] [Abstract][Full Text] [Related]
6. Predictive validity of a MK-801-induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinically. Brown JW; Rueter LE; Zhang M Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():53-62. PubMed ID: 24269664 [TBL] [Abstract][Full Text] [Related]
7. Prolonged reversal of the phencyclidine-induced impairment in novel object recognition by a serotonin (5-HT)1A-dependent mechanism. Horiguchi M; Miyauchi M; Neugebauer NM; Oyamada Y; Meltzer HY Behav Brain Res; 2016 Mar; 301():132-41. PubMed ID: 26342283 [TBL] [Abstract][Full Text] [Related]
8. RP5063, an atypical antipsychotic drug with a unique pharmacologic profile, improves declarative memory and psychosis in mouse models of schizophrenia. Rajagopal L; Kwon S; Huang M; Michael E; Bhat L; Cantillon M; Meltzer HY Behav Brain Res; 2017 Aug; 332():180-199. PubMed ID: 28373127 [TBL] [Abstract][Full Text] [Related]
9. Prevention of the phencyclidine-induced impairment in novel object recognition in female rats by co-administration of lurasidone or tandospirone, a 5-HT(1A) partial agonist. Horiguchi M; Hannaway KE; Adelekun AE; Jayathilake K; Meltzer HY Neuropsychopharmacology; 2012 Sep; 37(10):2175-83. PubMed ID: 22739469 [TBL] [Abstract][Full Text] [Related]
10. NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update. Cadinu D; Grayson B; Podda G; Harte MK; Doostdar N; Neill JC Neuropharmacology; 2018 Nov; 142():41-62. PubMed ID: 29196183 [TBL] [Abstract][Full Text] [Related]
11. The role of serotonin receptors in the action of atypical antipsychotic drugs. Meltzer HY; Massey BW Curr Opin Pharmacol; 2011 Feb; 11(1):59-67. PubMed ID: 21420906 [TBL] [Abstract][Full Text] [Related]
13. Donepezil and the alpha-7 agonist PHA 568487, but not risperidone, ameliorate spatial memory deficits in a subchronic MK-801 mouse model of cognitive impairment in schizophrenia. Karamihalev S; Prickaerts J; van Goethem NP Behav Brain Res; 2014 Oct; 272():248-51. PubMed ID: 25036424 [TBL] [Abstract][Full Text] [Related]
14. Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology. Neill JC; Grayson B; Kiss B; Gyertyán I; Ferguson P; Adham N Eur Neuropsychopharmacol; 2016 Jan; 26(1):3-14. PubMed ID: 26655189 [TBL] [Abstract][Full Text] [Related]
15. Dopamine D Miyauchi M; Neugebauer NM; Meltzer HY J Psychopharmacol; 2017 Apr; 31(4):442-452. PubMed ID: 28347261 [TBL] [Abstract][Full Text] [Related]
16. SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia. Pichat P; Bergis OE; Terranova JP; Urani A; Duarte C; Santucci V; Gueudet C; Voltz C; Steinberg R; Stemmelin J; Oury-Donat F; Avenet P; Griebel G; Scatton B Neuropsychopharmacology; 2007 Jan; 32(1):17-34. PubMed ID: 16936709 [TBL] [Abstract][Full Text] [Related]
17. Interaction of mGlu2/3 agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats. Horiguchi M; Huang M; Meltzer HY Psychopharmacology (Berl); 2011 Sep; 217(1):13-24. PubMed ID: 21432027 [TBL] [Abstract][Full Text] [Related]
18. Clozapine and glycinamide prevent MK-801-induced deficits in the novel object recognition (NOR) test in the domestic rabbit (Oryctolagus cuniculus). Hoffman KL; Basurto E Behav Brain Res; 2014 Sep; 271():203-11. PubMed ID: 24933188 [TBL] [Abstract][Full Text] [Related]
19. The role of 5-hydroxytryptamine 7 receptors in the phencyclidine-induced novel object recognition deficit in rats. Horiguchi M; Huang M; Meltzer HY J Pharmacol Exp Ther; 2011 Aug; 338(2):605-14. PubMed ID: 21558435 [TBL] [Abstract][Full Text] [Related]
20. Neurosteroid pregnenolone sulfate, alone, and as augmentation of lurasidone or tandospirone, rescues phencyclidine-induced deficits in cognitive function and social interaction. Rajagopal L; Soni D; Meltzer HY Behav Brain Res; 2018 Sep; 350():31-43. PubMed ID: 29763637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]